FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:YEATS4-XRCC6BP1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: YEATS4-XRCC6BP1
FusionPDB ID: 99988
FusionGDB2.0 ID: 99988
HgeneTgene
Gene symbol

YEATS4

XRCC6BP1

Gene ID

8089

91419

Gene nameYEATS domain containing 4ATP23 metallopeptidase and ATP synthase assembly factor homolog
Synonyms4930573H17Rik|B230215M10Rik|GAS41|NUBI-1|YAF9KUB3|XRCC6BP1
Cytomap

12q15

12q14.1

Type of geneprotein-codingprotein-coding
DescriptionYEATS domain-containing protein 4NuMA binding protein 1glioma-amplified sequence 41nuBI1mitochondrial inner membrane protease ATP23 homologKu70-binding protein 3XRCC6-binding protein 1
Modification date2020031320200320
UniProtAcc..
Ensembl transtripts involved in fusion geneENST idsENST00000247843, ENST00000548020, 
ENST00000546709, ENST00000300145, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score19 X 5 X 9=85518 X 7 X 5=630
# samples 2221
** MAII scorelog2(22/855*10)=-1.9584208962486
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(21/630*10)=-1.58496250072116
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: YEATS4 [Title/Abstract] AND XRCC6BP1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: YEATS4 [Title/Abstract] AND XRCC6BP1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)YEATS4(69764755)-XRCC6BP1(58339411), # samples:2
Anticipated loss of major functional domain due to fusion event.YEATS4-XRCC6BP1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
YEATS4-XRCC6BP1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
YEATS4-XRCC6BP1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
YEATS4-XRCC6BP1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneYEATS4

GO:0043967

histone H4 acetylation

14966270

HgeneYEATS4

GO:0043968

histone H2A acetylation

14966270



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:69764755/chr12:58339411)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across YEATS4 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across XRCC6BP1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000247843YEATS4chr1269764755+ENST00000300145XRCC6BP1chr1258339410+17177841711337388
ENST00000548020YEATS4chr1269764755+ENST00000300145XRCC6BP1chr1258339410+15486151641168334
ENST00000247843YEATS4chr1269764755+ENST00000300145XRCC6BP1chr1258339411+17177841711337388
ENST00000548020YEATS4chr1269764755+ENST00000300145XRCC6BP1chr1258339411+15486151641168334

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000247843ENST00000300145YEATS4chr1269764755+XRCC6BP1chr1258339410+0.000626770.99937326
ENST00000548020ENST00000300145YEATS4chr1269764755+XRCC6BP1chr1258339410+0.0002588760.99974114
ENST00000247843ENST00000300145YEATS4chr1269764755+XRCC6BP1chr1258339411+0.000626770.99937326
ENST00000548020ENST00000300145YEATS4chr1269764755+XRCC6BP1chr1258339411+0.0002588760.99974114

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for YEATS4-XRCC6BP1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
YEATS4chr1269764755XRCC6BP1chr1258339410615151QLTLGAYKHETEYPYVKLLLDAMKHS
YEATS4chr1269764755XRCC6BP1chr1258339410784205QLTLGAYKHETEYPYVKLLLDAMKHS
YEATS4chr1269764755XRCC6BP1chr1258339411615151QLTLGAYKHETEYPYVKLLLDAMKHS
YEATS4chr1269764755XRCC6BP1chr1258339411784205QLTLGAYKHETEYPYVKLLLDAMKHS

Top

Potential FusionNeoAntigen Information of YEATS4-XRCC6BP1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
YEATS4-XRCC6BP1_69764755_58339410.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B47:01TEYPYVKL0.99930.67631018
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B18:01TEYPYVKL0.99870.96951018
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B35:03YPYVKLLL0.99770.7941220
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B35:02YPYVKLLL0.98270.84651220
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B35:04YPYVKLLL0.98270.84651220
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B52:01TEYPYVKL0.95240.79391018
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B39:13TEYPYVKL0.87840.95441018
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B13:01TEYPYVKLL0.98550.84661019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B44:03TEYPYVKLL0.98530.95861019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B47:01TEYPYVKLL0.97910.59711019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B50:02TEYPYVKLL0.97740.55991019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B38:01KHETEYPYV0.9650.9869716
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B18:01TEYPYVKLL0.96240.9481019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B14:02TEYPYVKLL0.95130.52331019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B14:01TEYPYVKLL0.95130.52331019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B45:01TEYPYVKLL0.91110.7621019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B47:01HETEYPYVK0.72970.7243817
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B41:01TEYPYVKLL0.47190.82561019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B39:13TEYPYVKLL0.45830.93641019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B15:18YKHETEYPY0.45570.8015615
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B15:03YKHETEYPY0.44790.8479615
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B38:02TEYPYVKLL0.38730.96641019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B50:01TEYPYVKLL0.26960.71871019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B52:01TEYPYVKLL0.25480.72431019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B15:37TEYPYVKLL0.25010.69441019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B15:10TEYPYVKLL0.19480.72111019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B47:01YKHETEYPY0.08290.6469615
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B47:01HETEYPYVKL0.99690.6819818
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B47:01TEYPYVKLLL0.9680.52681020
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B44:03TEYPYVKLLL0.95190.94721020
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B39:13HETEYPYVKL0.8260.9736818
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B39:13TEYPYVKLLL0.65780.92781020
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B44:03ETEYPYVKLL0.47910.9614919
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B35:05YPYVKLLLDAM0.99520.55811223
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B35:03YPYVKLLLDAM0.99290.77871223
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B40:06TEYPYVKL0.99990.62491018
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B14:03YPYVKLLL0.99370.5421220
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B35:12YPYVKLLL0.98270.84651220
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B39:10YPYVKLLL0.96150.73021220
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B39:08TEYPYVKL0.94790.84971018
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B51:07TEYPYVKL0.91930.67921018
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B40:06TEYPYVKLL0.99810.57021019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B15:31YKHETEYPY0.83410.9502615
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B15:21YKHETEYPY0.76620.9362615
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C07:19YKHETEYPY0.75040.8101615
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C07:80YKHETEYPY0.67580.9508615
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C07:67YKHETEYPY0.67580.9508615
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C07:10YKHETEYPY0.66020.9682615
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C07:95TEYPYVKLL0.65180.75191019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C07:46YKHETEYPY0.65040.8956615
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B14:03TEYPYVKLL0.55050.71471019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B39:09TEYPYVKLL0.54970.54521019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B39:08TEYPYVKLL0.53340.79491019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C07:13EYPYVKLLL0.40840.87911120
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C07:29EYPYVKLLL0.3850.9251120
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B39:05TEYPYVKLL0.37190.91081019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C07:67EYPYVKLLL0.36330.89141120
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C07:80EYPYVKLLL0.36330.89141120
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C07:10EYPYVKLLL0.33540.92691120
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C12:16TEYPYVKLL0.2760.97081019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B51:07TEYPYVKLL0.12340.61271019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C01:30EYPYVKLLL0.09090.94141120
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C12:16YKHETEYPY0.08030.9676615
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B39:08HETEYPYVKL0.87550.915818
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B42:02YPYVKLLLDAM0.99780.67961223
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B40:04TEYPYVKL0.99970.74411018
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B18:05TEYPYVKL0.99870.96951018
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B18:08TEYPYVKL0.99860.92161018
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B18:04TEYPYVKL0.99850.97351018
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B18:06TEYPYVKL0.99840.9731018
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B18:03TEYPYVKL0.99780.9661018
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B35:13YPYVKLLL0.99750.80561220
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B18:11TEYPYVKL0.99030.96751018
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B67:01YPYVKLLL0.9850.5571220
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B35:09YPYVKLLL0.98270.84651220
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B41:03TEYPYVKL0.98090.5131018
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B35:24YPYVKLLL0.97040.76831220
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B39:02TEYPYVKL0.91270.95591018
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B18:07YPYVKLLL0.80360.6851220
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B40:04TEYPYVKLL0.99660.68291019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B44:26TEYPYVKLL0.98530.95861019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B44:13TEYPYVKLL0.98530.95861019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B44:07TEYPYVKLL0.98530.95861019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B18:04TEYPYVKLL0.97640.95741019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B18:08TEYPYVKLL0.97020.87961019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B18:07TEYPYVKLL0.96890.91371019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B38:05KHETEYPYV0.9650.9869716
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B18:05TEYPYVKLL0.96240.9481019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B18:06TEYPYVKLL0.93650.95331019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B18:03TEYPYVKLL0.92520.94291019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-A68:02ETEYPYVKL0.86480.592918
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B18:06HETEYPYVK0.79930.985817
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B35:20YKHETEYPY0.78840.9639615
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C07:17YKHETEYPY0.710.9704615
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B18:11TEYPYVKLL0.70080.94231019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B35:28YKHETEYPY0.67990.9638615
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C07:02YKHETEYPY0.67580.9508615
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-A69:01ETEYPYVKL0.61610.881918
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B39:11KHETEYPYV0.56010.8972716
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B39:11TEYPYVKLL0.48770.75861019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C06:06TEYPYVKLL0.48420.98641019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C07:22TEYPYVKLL0.47910.82251019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B39:02TEYPYVKLL0.46740.93431019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B39:31TEYPYVKLL0.46310.91851019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B18:04YKHETEYPY0.43280.968615
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C06:02TEYPYVKLL0.40260.99551019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C06:17TEYPYVKLL0.40260.99551019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B48:02YKHETEYPY0.36520.9576615
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C07:02EYPYVKLLL0.36330.89141120
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C06:08TEYPYVKLL0.32360.9911019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C07:17EYPYVKLLL0.30640.93361120
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B50:05TEYPYVKLL0.26960.71871019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B50:04TEYPYVKLL0.26960.71871019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B48:02TEYPYVKLL0.2560.9491019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B18:06YKHETEYPY0.23670.965615
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B18:07YKHETEYPY0.23020.9543615
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B15:53YKHETEYPY0.19360.9468615
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C14:02EYPYVKLLL0.1740.91951120
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C14:03EYPYVKLLL0.1740.91951120
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B18:08YKHETEYPY0.16290.9457615
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-C04:04EYPYVKLLL0.14820.71461120
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B15:54YKHETEYPY0.11110.9413615
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B15:09TEYPYVKLL0.09670.5981019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B15:53TEYPYVKLL0.06760.93631019
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B15:68YKHETEYPY0.01430.7954615
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B40:04HETEYPYVKL0.99730.7274818
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B40:04TEYPYVKLLL0.98540.65371020
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B44:26TEYPYVKLLL0.95190.94721020
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B44:13TEYPYVKLLL0.95190.94721020
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B44:07TEYPYVKLLL0.95190.94721020
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B41:03HETEYPYVKL0.8340.6663818
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B39:02HETEYPYVKL0.81020.9736818
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-A68:02ETEYPYVKLL0.67830.5165919
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B44:07ETEYPYVKLL0.47910.9614919
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B44:26ETEYPYVKLL0.47910.9614919
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B44:13ETEYPYVKLL0.47910.9614919
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B35:30YPYVKLLLDAM0.99590.65311223
YEATS4-XRCC6BP1chr1269764755chr1258339410784HLA-B35:17YPYVKLLLDAM0.99590.65311223

Top

Potential FusionNeoAntigen Information of YEATS4-XRCC6BP1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
YEATS4-XRCC6BP1_69764755_58339410.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
YEATS4-XRCC6BP1chr1269764755chr1258339410784DRB1-1216TLGAYKHETEYPYVK217
YEATS4-XRCC6BP1chr1269764755chr1258339410784DRB1-1216LGAYKHETEYPYVKL318
YEATS4-XRCC6BP1chr1269764755chr1258339410784DRB1-1222TLGAYKHETEYPYVK217
YEATS4-XRCC6BP1chr1269764755chr1258339410784DRB1-1222LGAYKHETEYPYVKL318

Top

Fusion breakpoint peptide structures of YEATS4-XRCC6BP1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
10695YKHETEYPYVKLLLYEATS4XRCC6BP1chr1269764755chr1258339410784

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of YEATS4-XRCC6BP1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN10695YKHETEYPYVKLLL-7.15543-7.26883
HLA-B14:023BVN10695YKHETEYPYVKLLL-4.77435-5.80965
HLA-B52:013W3910695YKHETEYPYVKLLL-6.80875-6.92215
HLA-B52:013W3910695YKHETEYPYVKLLL-4.20386-5.23916
HLA-A11:014UQ210695YKHETEYPYVKLLL-7.5194-8.5547
HLA-A11:014UQ210695YKHETEYPYVKLLL-6.9601-7.0735
HLA-A24:025HGA10695YKHETEYPYVKLLL-7.52403-7.63743
HLA-A24:025HGA10695YKHETEYPYVKLLL-5.82433-6.85963
HLA-B27:056PYJ10695YKHETEYPYVKLLL-3.28285-4.31815
HLA-B44:053DX810695YKHETEYPYVKLLL-5.91172-6.94702
HLA-B44:053DX810695YKHETEYPYVKLLL-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of YEATS4-XRCC6BP1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
YEATS4-XRCC6BP1chr1269764755chr12583394101018TEYPYVKLAAACAGAATATCCATATGTCAAAC
YEATS4-XRCC6BP1chr1269764755chr12583394101019TEYPYVKLLAAACAGAATATCCATATGTCAAACTTC
YEATS4-XRCC6BP1chr1269764755chr12583394101020TEYPYVKLLLAAACAGAATATCCATATGTCAAACTTCTGC
YEATS4-XRCC6BP1chr1269764755chr12583394101120EYPYVKLLLCAGAATATCCATATGTCAAACTTCTGC
YEATS4-XRCC6BP1chr1269764755chr12583394101220YPYVKLLLAATATCCATATGTCAAACTTCTGC
YEATS4-XRCC6BP1chr1269764755chr12583394101223YPYVKLLLDAMAATATCCATATGTCAAACTTCTGCTTGATGCTA
YEATS4-XRCC6BP1chr1269764755chr1258339410615YKHETEYPYCCTATAAGCATGAAACAGAATATCCAT
YEATS4-XRCC6BP1chr1269764755chr1258339410716KHETEYPYVATAAGCATGAAACAGAATATCCATATG
YEATS4-XRCC6BP1chr1269764755chr1258339410817HETEYPYVKAGCATGAAACAGAATATCCATATGTCA
YEATS4-XRCC6BP1chr1269764755chr1258339410818HETEYPYVKLAGCATGAAACAGAATATCCATATGTCAAAC
YEATS4-XRCC6BP1chr1269764755chr1258339410918ETEYPYVKLATGAAACAGAATATCCATATGTCAAAC
YEATS4-XRCC6BP1chr1269764755chr1258339410919ETEYPYVKLLATGAAACAGAATATCCATATGTCAAACTTC

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
YEATS4-XRCC6BP1chr1269764755chr1258339410217TLGAYKHETEYPYVKTAACATTAGGAGCCTATAAGCATGAAACAGAATATCCATATGTCA
YEATS4-XRCC6BP1chr1269764755chr1258339410318LGAYKHETEYPYVKLCATTAGGAGCCTATAAGCATGAAACAGAATATCCATATGTCAAAC

Top

Information of the samples that have these potential fusion neoantigens of YEATS4-XRCC6BP1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
GBMYEATS4-XRCC6BP1chr1269764755ENST00000247843chr1258339410ENST00000300145TCGA-06-0138

Top

Potential target of CAR-T therapy development for YEATS4-XRCC6BP1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to YEATS4-XRCC6BP1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to YEATS4-XRCC6BP1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource